Open
SectorHealthcare
2.14 -3.17
24h
Min
2.14
Max
2.27
Income | 4.5M -112M |
---|---|
Sales | 11M 60M |
Profit margin | -186.246 |
Employees | 838 |
EBITDA | 8.3M -102M |
Recommendations | Strong Buy |
---|---|
12 Months Forecast | +462.5% upside |
Next Earnings | 6 Nov 2025 |
---|
Market Cap | -171M 774M |
---|---|
Previous open | 5.31 |
Previous close | 2.14 |
By Acuity
50%
50%
170 / 371 Healthcare
By Trading Central
Confidence
Strong Bearish Evidence
Past performance is not a reliable indicator of future results.
Price change
By TipRanks
12 Months Forecast
Average 12.6 USD 462.5%
High 20 USD
Low 4 USD
Based on 6 Wall Street analysts offering 12 month price targets forIovance Biotherapeutics Inc - Dist in the last 3 months.
By Acuity
News Sentiment
Neutral
Volatility
Below average
News Volume (RCV)
Average
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$